Feedback

Six Jobs That Won't Exist

Regarding your prediction ("Six Jobs That Won't Exist In 2016," March) that ad creatives will be gone in 10 years: Maybe I'm in denial because I'm an ad copywriter, but I've seen the result of amateurs trying to write TV or radio ads--and especially jingles. Everyone thinks he can do it. I'll start practicing my skills waiting tables or whatever I'll need to work at Wal-Mart, but if you think you hate advertising now, wait until the amateurs get a hold of it.

Greg Booth
Tucson, Arizona

I agree that the position of auto mechanic won't be the same as it was. Auto mechanics will need to be more technologically adept. But the position will not go away; it'll just become more complex. How far would the Enterprise have gone without Scotty?

Alicia Hothem
Haltom City, Texas

Let's Hear It for the Kids

Thank you for quoting an intelligent high schooler in "Open Debate" (March). Shannon O'Brien was clear and insightful in sharing the importance of personal relationships, while I think John Seely Brown exemplified his title of "chief of confusion."

Tim Schaafsma
Lynden, Washington

Not So Intelligent

Your celebration of Judge Jones's decision to keep intelligent design out of the classroom is outlandish and ridiculous ("Jurisprudent," March). Society works to foster an environment of support and acceptance for any idea, unless that idea smacks of faith. Intelligent-design theory is the least of our worries. Let's start with something concrete such as competent teachers and better pay.

Julie Claggett
Oklahoma City, Oklahoma

Fast Fixes

In our March Fast 50 article on the Predator drone ("Combat Drones"), we pictured the wrong aircraft. We also used an incorrect title for Thomas J. Cassidy Jr.; he is now the president of Aircraft Systems Group, General Atomics Aeronautical Systems Inc.

In "The Mintz Dynasty" (April), we misidentified Dan Mintz's company. It is Dynamic Marketing Group.

"The Biotech Innovation Scorecard" (December 2005) should have described Idenix Pharmaceuticals' Telbivudine as a treatment for hepatitis B, not a vaccine.

How to Give Feedback

Send us an email (loop@fastcompany.com) Submission of a letter constitutes permission to publish it in any form or medium. Letters may be edited for reasons of space and clarity.

Join the Company of Friends The Fast Company readers' network has thousands of members in 200 chapters around the world.